Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 9Wilms Tumor 2Pancreatic Neoplasms 2Kidney Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hepatic Veno-Occlusive Disease 1Genetic Predisposition to Disease 1Colorectal Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Radiotherapy 2Ifosfamide 2Filgrastim 2Everolimus 2Doxorubicin 2vatalanib 1tipifarnib 1temsirolimus 1spartalizumab 1pentetreotide 1pembrolizumab 1guadecitabine 1gallium Ga 68 dotatate 1fostamatinib 1belzutifan 1Vinorelbine 1Specimen Handling 1Sirolimus 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Indinavir 1Immunotherapy 1High-Energy Shock Waves 1Genetic Testing 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × Genetic Testing × Genitourinary × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡